Israel - English - Ministry of Health

sanofi - aventis israel ltd - buserelin acetate - rods for implant - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).

Israel - English - Ministry of Health

sanofi israel ltd - zolpidem tartrate - film coated tablets - zolpidem tartrate 10 mg - zolpidem - zolpidem - indications are limited to treatment of severe sleep disorders in the following cases: - occasional insomnia - transient insomnia.

Israel - English - Ministry of Health

sanofi israel ltd - polystyrene sulphonate sodium - powder for suspension - polystyrene sulphonate sodium 99.934 % - polystyrene sulfonate - polystyrene sulfonate - treatment of hyperkalemia.

United States - English - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - dronedarone (unii: jqz1l091y2) (dronedarone - unii:jqz1l091y2) - dronedarone 400 mg - multaq® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation (af) [see clinical studies (14)] . multaq is contraindicated in patients with: - permanent atrial fibrillation (patients in whom normal sinus rhythm will not or cannot be restored) [see boxed warning, warnings and precautions (5.2)] - symptomatic heart failure with recent decompensation requiring hospitalization or nyha class iv symptoms [see boxed warning, warnings and precautions (5.1)] - second or third-degree atrioventricular (av) block, or sick sinus syndrome (except when used in conjunction with a functioning pacemaker) - bradycardia <50 bpm - concomitant use of strong cyp3a inhibitors, such as ketoconazole, itraconazole, voriconazole, cyclosporine, telithromycin, clarithromycin, nefazodone, and ritonavir [see drug interactions (7.2)] - concomitant use of erythromycin [see clinical pharmacology (12.3)] - concomitant use of drugs or

Israel - English - Ministry of Health

sanofi israel ltd - spiramycin - film coated tablets - spiramycin 1.5 miu - spiramycin - respiratory tract infections, infections caused by clamydia, cryptosporidiosis pregnancy toxoplasmosis.

Israel - English - Ministry of Health

sanofi - aventis israel ltd - roxithromycin - film coated tablets - roxithromycin 150 mg - roxithromycin - for the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ent bronchopulmonary, genital and skin manifestations.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - docetaxel -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - docetaxel -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - clopidogrel hydrogen sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - clopidogrel hydrogen sulfate; clopidogrel -